Introduction: Currently, there have been limited data on the presence of antiphospholipid antibodies (aPLs) in patients with uterine malignancies (UMs). Objectives: We aimed to determine whether ...

APLS board member and ALGOP chairman John Wahl ... Approve written selection criteria for minors that prevents the purchase or otherwise acquiring of any material advertised for consumers younger ...

APELLIS PHARMACEUTICALS INC (APLS) is a mid-cap growth stock in the ... the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are ...

APELLIS PHARMACEUTICALS INC (APLS) is a mid-cap value stock in the ... the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent ...

Apellis Pharmaceuticals APLS provided third-quarter 2023 preliminary revenues guidance for its recently launched drug, Syfovre (pegcetacoplan injection), for the treatment of geographic atrophy ...